Tuberculosis, multidrug-resistant
Clinical trials for Tuberculosis, multidrug-resistant explained in plain language.
Never miss a new study
Get alerted when new Tuberculosis, multidrug-resistant trials appear
Sign up with your email to follow new studies for Tuberculosis, multidrug-resistant, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a 4-Drug combo cut TB treatment time in half?
Disease control CompletedThis trial tests a new combination of four drugs, called BPaMZ, for treating tuberculosis. People with drug-sensitive TB receive BPaMZ for 4 months, compared to the standard 6-month regimen. People with drug-resistant TB receive BPaMZ for 6 months. The study measures how well the…
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Phase 2/3 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can a shorter TB drug combo beat Drug-Resistant TB?
Disease control CompletedThis study tested two different doses of the antibiotic linezolid, combined with three other drugs (bedaquiline, delamanid, and clofazimine), in 138 people with drug-resistant pulmonary tuberculosis. The goal was to see which dose worked better at clearing the infection and was e…
Matched conditions: TUBERCULOSIS, MULTIDRUG-RESISTANT
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC